Skip to main content
. Author manuscript; available in PMC: 2017 Mar 15.
Published in final edited form as: Cancer. 2016 Jan 13;122(6):946–953. doi: 10.1002/cncr.29872

Table 3.

Multiple regression model for mtDNA copy number for DOX alone versus DEX+DOX

Variable Coefficient (β) SE P-value
Intercept 2.60 0.28 <0.001
Treatment (DOX alone versus DEX+DOX) 0.46 0.13 0.001
Sex (male versus female) 0.11 0.14 0.45
Agea (<10 versus ≥10 years) 0.02 0.14 0.89
Immunophenotype (B-cell versus T-cell) -0.18 0.21 0.41
RBC contamination (no versus yes) 0.02 0.14 0.89
Initial WBC -0.0006 0.001 0.60
a

Age at the time of protocol registration.

DOX, doxorubicin; DEX, dexrazoxane; DEX+DOX, administration of dexrazoxane prior to every doxorubicin treatment; RBC, red blood cell; SE, standard error; WBC, white blood cell count.